Rigel Pharmaceuticals Inc (NASDAQ:RIGL) has 147 institutional investors with active 13F positions as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 1,768,907 | 104,697 | 6.29% | $47,831,252.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 1,280,000 | 444,000 | 53.11% | $34,611,200.00 |
| State Street Corp | 31 Mar, 2026 | 1,120,238 | 29,015 | 2.66% | $30,291,236.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 764,193 | 764,193 | 0.00% | $20,663,779.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 666,426 | 172,822 | 35.01% | $18,009.00 |
| LSV ASSET MANAGEMENT | 31 Mar, 2026 | 601,507 | 57,225 | 10.51% | $16,265.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 598,378 | -15,222 | -2.48% | $16,180,140.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Mar, 2026 | 544,431 | 289,939 | 113.93% | $14,721,414.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 445,678 | 21,362 | 5.03% | $12,051,133.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 440,626 | 16,312 | 3.84% | $11,917,730.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 439,101 | -904,655 | -67.32% | $11,873,291.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 405,807 | 134,579 | 49.62% | $10,973,021.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 379,541 | 102,729 | 37.11% | $10,259,398.00 |
| Qube Research & Technologies Ltd | 31 Mar, 2026 | 343,897 | 55,628 | 19.30% | $9,298,975.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 338,441 | -200,568 | -37.21% | $9,151,445.00 |
| Nuveen, LLC | 31 Mar, 2026 | 337,427 | 78,534 | 30.33% | $9,124,026.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 271,754 | 235,536 | 650.33% | $7,348,228.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 264,410 | -167,050 | -38.72% | $7,149,646.00 |
| CM Management, LLC | 31 Mar, 2026 | 235,000 | 10,000 | 4.44% | $6,354,400.00 |
| GLOBEFLEX CAPITAL L P | 31 Mar, 2026 | 217,839 | 0 | 0.00% | $5,890,367.00 |